Valeant (VRX) Audit Head Oversaw Similar Role At A Fraud

Norma Provencio, who currently leads Valeant Pharmaceuticals board’s audit committee, was previously a director of a publicly traded company that failed after the government cracked down on a half-decade of fraud beginning in 2005. Provencio was an accounting consultant before Signalife’s public offering, and starting in mid-2005, she was a director in charge of the board’s audit committee. Valeant Pharma allegedly involved in accounting fraud As outlined by ValueWalk, last October, a research report from Citron Research claimed Valeant is a part of an Enron-like fraud. The Citron research piece highlights shady relationships with Philidor RX Services, a Hatboro, PA…